Papers
4
Total Citations
71
H-Index
4
About
Amanjit Bal is a pioneering researcher in interventional oncology and molecular imaging, best known for advancing the integration of real-time PET/CT guidance with automated robotic-arm-assisted needle navigation for percutaneous biopsies. His major contributions center on the development and clinical validation of a novel, minimally invasive technique that uses hypermetabolic lesion targeting—primarily with ¹⁸F-FDG and ⁶⁸Ga-avid tracers—to improve diagnostic accuracy and reduce procedural risks in challenging anatomical sites. His landmark 2018 study on PET/CT-guided robotic biopsy of bone lesions (29 citations) demonstrated high diagnostic performance and clinical impact, while subsequent work extended this approach to abdominal and pelvic lesions (21 citations) and Ga-68 avid tumors (17 citations). Bal’s research has established a new paradigm for image-guided biopsy, offering real-time precision that traditional methods cannot achieve. He has also contributed to the field of transoral robotic surgery (TORS) for oropharyngeal cancer, analyzing outcomes in both recurrent and new T1-T2 tumors. With a growing citation footprint and a focus on translating cutting-edge robotics into routine clinical practice, Bal’s work continues to shape the future of interventional radiology and oncologic diagnostics.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4